Skip to main content
. 2016 Jan 20;59(1):26–36. doi: 10.3340/jkns.2016.59.1.26

Fig. 1. Two representative glioblastoma pyrograms. Five consecutive positions are analyzed for CpGs; the last one is an internal control for bisulfite treatment. Each C peak in a yellow background represents the methylation percentage for each CpG. A : Unmethylated MGMT promoter of a glioblastoma sample. B : Methylated MGMT promoter of a glioblastoma sample.

Fig. 1